In this study, the mechanism of the xanthine oxidase (XO) inhibitory activity of pyrogallol, the main inhibitor found in roasted coffee, was investigated. Pyrogallol was unstable and readily converted to purpurogallin in a pH 7.4 solution, a physiological model of human body fluids. The XO inhibitory activity of the produced purpurogallin was higher than that of pyrogallol, as evidenced by comparing their IC 50 values (0.2 µmol L ), its XO inhibitory activity was also enhanced by pre-incubation in the pH 7.4 solution. In contrast, 5-methylpyrogallol, which could not be transformed into corresponding purpurogallin derivatives, did not show XO inhibitory activity before or after incubation in pH 7.4 solution. Molecular docking simulations clarified that purpurogallins have stronger affinities for XO than corresponding pyrogallols. These results revealed that the potent XO inhibitory activity seemingly observed in pyrogallol is actually derived from its chemical conversion, under alkaline conditions, into purpurogallin.
Introduction
Xanthine oxidase (XO), the final enzyme in purine catabolism of humans, catalyses the oxidation reactions of hypoxanthine and xanthine. The reactions produce uric acid and reactive oxygen species such as superoxide and hydrogen peroxide. It is well known that the onset of gout is due to an over-accumulation of plasma uric acid: this over-accumulation is believed to be related to eating habits [1] . Therefore, in spite of being a classical disease, gout is now also recognized as a current lifestyle-related disease, with recent increases in the number of patients experiencing it [2] . Cardiovascular disease is another lifestyle-related disease, and it is well known to be related to oxidative stress caused by superoxide, hydrogen peroxide, nitric oxide, and their metabolites (hydroxyl radical, peroxynitrite, etc.) [3] . Thus, inhibition of the over-working of XO is important in preventing such lifestyle-related diseases [4] . For gout treatment, several synthetic XO inhibitors were developed in the 1950s and1960s; however, they are toxic to human organs [5] . Therefore, several recent investigations have sought safer and more effective XO inhibitors from natural sources, including foods and traditional herbs [6] . Coffee is the most popular beverage in the world; it is comes from the beans of tropical Caffea arabica trees (and related species), and is made by roasting, grinding, and brewing the beans. In epidemiological studies published in 2007, Choi et al. [7] reported that a coffee drinking habit significantly reduces the incidence of gout. They also showed that coffee reduced uric acid levels in the serum of in coffee drinkers [8, 9] . These results indicated that coffee could be a promising source of the XO inhibitors, and prompted us to seek those inhibitory compounds in coffee as candidates for medicines to treat gout. In a previous study, we observed that XOinhibitory activity only in roasted coffee beans, and not in green or dried beans [10] . We have also isolated XO inhibitors from hot-water extracts of roasted coffee beans, and identified them as pyrogallol and several chlorogenic lactones [11] . Based on quantitative analyses and evaluations of the respective activity efficiencies of XO inhibitors, we hypothesized that pyrogallol was the main contributor of the XOinhibitory activities in roasted coffee.
Pyrogallol (1,2,3-trihydroxybenzene) is a simple polyphenol that bears the decarboxylated structure of gallic acid, which itself is distributed widely in plants as a component of hydrolysable tannin. Polyphenols have high reactivity for radical trapping and reducing reactions [12] , and this reactivity is enhanced under alkaline conditions [13] . Therefore, the high reactivity and resulting structural changes of pyrogallol must be studied chemically to clarify its XO-inhibitory mechanism. In this paper, we report on the relation between pyrogallol's XO inhibition and reactivity at pH 7.4 as a model of physiological conditions, and we discuss the results of our simulations of the molecular docking of pyrogallol (and its related substances) with XO.
Materials and methods

Materials
Pyrogallol, 5-methylpyrogallol, and 2,3,4-trihydroxybenzaldehyde were purchased from Tokyo Kasei (Tokyo, Japan). Sodium cyanoborohydride was purchased from Sigma-Aldrich Japan (Tokyo, Japan). Xanthine oxidase from buttermilk (ca. 0.3 units mg −1 ) was obtained from Oriental Yeast (Tokyo, Japan). All other reagents and solvents were purchased as extra pure grade or HPLC grade from Nacalai Tesque (Kyoto, Japan).
General procedure
NMR spectra were obtained from a JNM-ECZ400S (JEOL, Tokyo, Japan) using the manufacture provided pulse sequences. MS spectra were measured using a JMS-T100 spectrometer (JEOL) with direct analysis at real time (DART) ionization and time of flight (TOF) measuring mode under the following conditions: orifice 1, 10 V; orifice 2, 5 V; ring lens, 10 V; helium gas pressure, 0.5 MPa, flow rate of 10 L min
; ion resource temperature, 350°C; grid voltage positive, 400 V for positive mode. Elemental compositions of analyzed compounds were calculated using MassLynx software (v. 4.1, Waters, MA, USA). Analytical HPLC was performed using a PU-4180 quaternary gradient pump (JASCO, Tokyo, Japan) equipped with an MD-4015 photodiode array detector (JASCO), a CTO-10ASVP column oven (Shimadzu, Kyoto, Japan), and an AS-4150 intelligent sampler (JASCO). Data were analyzed using the ChromNAV software (v.2, JASCO). Preparative HPLC was performed using an LC-6 AD pump (Shimadzu) equipped with an SPD-6A UV detector (Shimadzu).
Assay for xanthine oxidase inhibition
The XO inhibitory assay was carried out according to a previously reported method, with modification [14] . The reaction medium consisted of 10 ) under various pH conditions. An aliquot (20 µL) was taken from the solution immediately after addition of pyrogallol and again after 10 min had elapsed. The solution was analyzed via HPLC under the following conditions. ; detection wavelength: 268 nm. These procedures were repeated using each of several phosphate buffer solutions of different pHs and the XO inhibitory activity of each solution was measured by the same procedure described above.
Preparation and identification of chemicals
4-Methylpyrogallol
To an acetic acid solution (10 mL) of 2,3,4-trihydroxybenzaldehyde (0.5 g) was added sodium cyanoborohydride (0.5 g) at 23°C, and then the solution was heated at 60°C with stirring for 2 h. After the solvent was removed under reduced pressure at 40°C, the obtained residue was purified by silica gel column chromatography (NAM-300H, Nagara Science, Gifu, Japan) eluted with CH 2 CH 2 -CH 3 OH=20:1-10:1 to give 4-methylpyrogalol (0.21 g). ; solvent A, [0.1% phosphoric acid in water]; solvent B, acetonitrile; gradient conditions, linear gradient of solvent B (5-45%, 0-40 min), then 100% (40-50 min), and then retention of 100% solvent B (50-55 min); detection wavelength, 268, 280, 300, and 428 nm. Produced purpurogallins were identified by comparing retention times and UV-vis spectra of specific peaks with the authentic samples synthesized as stated above.
Pyrogallols and purpurogallins in the reaction solutions were quantified via the external standard method, using the following equations. For pyrogallol, y=26,747x -1813 (where y= peak area at 268 nm, and x= amount of pyrogallol, ranging 0.25-5 nmol). For 4-methylpyrrogallol, y=50,629x -4 (where y= peak area at 268 nm, and x= amount of 4-methylpyrogallol, ranging 0.04-10 nmol). For 5-methylpyrrogallol, y=39,236x +767 (where y= peak area at 268 nm, and x= amount of 5-methylpyrogallol, ranging, 0.04-10 nmol). For purpurogallin, y=844,204x +535 (where y= peak area at 300 nm, and x= amount of purpurogallin, ranging, 0.005-0.1 nmol). For 1,7-dimethylpurpurogallin, y=1,307,266x +8831 (where y= peak area at 300 nm, and x= amount of 1,7-dimethylpurpurogallin, ranging, 0.004-1 nmol).
Additional 10 µL aliquots were taken from the reaction solutions at the same time intervals as were used for the XO inhibition assay. The aliquots were assayed immediately using the same procedure as described above (in pH 7.4 solution).
Kinetic studies of XO inhibition
These assays were carried out in various concentrations of xanthine (50-200 µmol L −1 ), with or without pyrogallol or purpurogallin, under conditions of no pre-incubation for the inhibitors (to prevent their degradation). Uric acid production was measured using the procedure described previously in the assay for XO inhibition, and reaction velocity was estimated by measuring uric acid concentration at 10 min after the start of the reaction. Lineweaver-Burk plotting was applied to determine the type of inhibition carried out by each inhibitor of XO activity.
Molecular docking simulations
Flexible-ligand molecular docking simulations were performed using the AutoDock Vina software application (v. 1.1.2; open-source). The crystal structure of the complex formed by bovine milk xanthine oxidase (XO) with salicylic acid (Protein Data Bank entry 1FIQ, resolution =2.5 Å) was obtained from the Protein Data Bank Japan (PDBj) database, and was prepared for docking using MGL Tools (v. 1.5.6.56; Scripps Research Institute, La Jolla, CA, USA). All water molecules and the ligand were removed, and hydrogens and Gasteiger partial charges were added. Three 30×30×30 grid boxes were positioned at three centres of the flexible parts of the complex (x 1 =26.79, y 1 =−9.95, z 1 =112.75; x 2 =19.42, y 2 =32.14, z 2 =100.72; and x 3 =27.04, y 3 =51.98, z 3 =100.72) with grid spacing of 1.00 Å, to cover the active site of XO molecule. The exhaustiveness parameter was set to 100. The ligand structure was created using the Chem3D Ultra software package (v. 13.0.0; PerkinElmer, MA, USA) with 3D structure optimization by MM2 add-in software. The visualization of the enzymeligand interaction for the molecular configuration with the lowest binding energy (the highest stability of the complex) was prepared using Pymol (v. 1.7.6.0; open-source, distributed by Schördinger). Detailed ligand-enzyme interactions were analyzed using LigPlot +(v.1.4; open-source, distributed by the European Bioinformatics Institute, Hinxton, UK).
Results and discussion
In a previous study, we concluded that pyrogallol was the main contributor to the XO-inhibitory activity of roasted coffee; however, in the current investigation, we found that the inhibitory activity of pyrogallol varied, depending on the duration of incubation time in the XO inhibition assay. Most assay of XO inhibition have been carried out under alkaline conditions, such as pH 7.8 or higher, because XO's catalytic activity is higher under the alkaline conditions [16] . It should be noted that, in an oxygen atmosphere, some polyphenols are unstable in such alkaline conditions, due to redox reactions. Fig. 1A shows the stability of pyrogallol when in solutions of various pH for 10 min at 37°C, which is the same reaction period of XO inhibition assay we employed. These results revealed that pyrogallol is stable at pH 5-6.5, but unstable at pH > 6.5. Fig. 1B shows XO activity in the presence and absence of inhibitors (pyrogallol and allopurinol) at identical pH conditions. XO activity decreased with the decreasing pH of the solution, and the XO-inhibitory activity (estimated from calculated percent inhibition) of pyrogallol almost disappeared in solutions with pH < 6.5. In contrast, allopurinol, a reference XO inhibitor, retained inhibitory activity under the identical pH conditions. These results indicated that some of pyrogallol's degraded products, which might be produced in solutions where pH > 6.5 could play roles in enhancing XO-inhibitory activity. Fig. 2 shows the HPLC analytical profile of pyrogallol when in pH 7.4 solution at 37°C for 0.5 h. This is a typical physiological pH, and the profile demonstrated that most of pyrogaloll was converted into new compound (indicated by peak 2). The new compound had a characteristic UV-vis absorption pattern (λmax 280, 300, 368, and 428 nm), indicating that the peak corresponded to purpurogallin (Fig. 3) . Purpurogallin is a dimeric compound derived from pyrogallol by a unique process of sequential oxidative dimerization and decarboxylation [17] . In addition to XO-inhibitory activity of pyrogallol [18] , the potent XO-inhibitory activity of purpurogallin [19] has been reported: it has also been reported to have several other biological activities, such as antioxidant activity in liver, kidney and cardiovascular cells were reported [20] [21] [22] [23] . Biological production of purpurogallin from pyrogallol has also been observed in human erythrocytes [24] . The identification of this new compound as purpurogallin was completed by comparing its retention time and UV-vis spectra of synthetically prepared purpurogallin.
When we measured the XO-inhibitory activities of purpurogallin and pyrogallol at pH 7.4, without pre-incubation (to prevent decomposition of the polyphenols), the data showed that both compounds have potent activities: for pyrogallol, IC 50 was 1.6 µmol L . Time-course measurements of XO-inhibitory activity, and concentrations of pyrogallol, and concentration of produced purpurogallin were then carried out in the pH 7.4 conditions. The resulting data displayed in Fig. 4 showed that the initial XO-inhibitory activity was 38% inhibition when the initial concentration of pyrogallol was 24 µmol L −1 of pyrogallol (the corresponding concentration in the XO inhibition assay solution was 1 µmol L −1 ). As the reaction proceeded, pyrogallol decreased (at a rate in accordance with a second-order reaction) until 2 h; however the purpurogallin concentration increased during the initial 30 min, and then decreased gradually. Additionally, XO-inhibitory activity increased around 40 min after reaction initiation, strongly indicating that the produced purpurogallin enhanced the XO-inhibitory activity occurring in the solution. Murakami and et al. [25] suggested that 5-methylpyrogallol could not be converted into purpurogallin derivatives. Dürckheimer and Pauhus [26] reported that the reaction between pyrogallol and 3,4-dimethylcatechol (which is analogous to 5-methylpyrogallol) did not produce the purpurogallin structure. We measured XO-inhibitory activity of two methyl-substituted pyrogallols, 4-methylpyrogallol and 5-methylpyrogallol, and we analyzed their conversion to purpurogallins, under identical reaction conditions. The resulting data are shown in Figs. 5 and 6. Fig. 5A and B show the HPLC analytical data for the pH 7.4 solutions of 4-methylpyrogallol and 5-methylpyrogallol, respectively. Here, we see that only 4-methylpyogallol gave a purpurogallin-like product, a compound that had a similar UV-vis absorption pattern (λmax 284, 308, 384, and 440 nm) to that of purpurogallin, at the retention time of 46 min. This purpurogallin-like compound derived from 4-methylpyrogallol was identical to 1,7-dimethylpurpurogalin, based on NMR and MS analyses (Fig. 3) . It should be noted that while 4-methylpyrogallol showed weak but certain initial XO-inhibitory activity (35% inhibition at a concentration of 10 µmol L −1
), 5-methylpyrogallol showed almost no XO-inhibitory activity at the same concentration (Fig. 6) . The time-course data also showed that 4-methylpyrogallol enhanced XO-inhibitory activity in a pattern similar to that of pyr-ogallol, while 5-methylpyrogallol did not enhance XO-inhibitory activity, as is shown in Fig. 6A . Next, kinetic analyses of XO inhibition were performed using various concentrations of the substrate, xanthine, in the presence of the XO inhibitors (pyrogallol and purpurogallin). The data are illustrated in Fig. 7 as Lineweaver-Burk plots. From these plots, and under the conditions employed, the Km value for xanthine was calculated to be 6.7 µmol L −1
. The plots also showed that the inhibition mechanism of pyrogallol and purpurogallin were of the same mixed type, this indicated that the molecular interactions between the XO-inhibitors and XO itself may occur in the active site of XO, including the region around the molybdopterin cofactor (the catalytic site of XO) [27] .
Recently, developed molecular docking software emerged as a useful tool for theoretical drug design. Computer-based simulations of small molecule (ligand)-protein interactions, including interactions occurring between enzymes and their inhibitors provide insight into the stability of such complex and also provide direct simulated images of the interaction sites by enabling visualizations of simulation results. Although many molecular docking software applications are now available [28] , we chose AutoDock Vina (developed and provided by Trott and Olson) [29] , because it has greater and more accurate calculating abilities; thus, we used it to estimate the contributions of pyrogallol itself and its derivative, purpurogallin, to the potent XOinhibitory activities attributed to pyrogallol. All of our docking simulations were of interaction between a molecule of interest and the active site of XO; the results are shown in Table 1 and Fig. 8 . The docking simulation for xanthine is shown in the left-top panel of Fig. 8 . It is well documented that the oxidation of xanthine into uric acid begins with the oxygenation of the carbon in the 8-positon by molybdenum (VI) ion in the molybdopterin cofactor of XO [30] . Although the predicted binding energy for this site and xanthine is not very low (−7.1 kcalmol −1 ) (Table 1) , the most stable binding conformation for xanthine
shows that the carbon in the 8-positon sits near (within 1.9 Å) the oxygen that is bound to the molybdenum atom, which indicated that our simulation using AutoDock Vina worked quite accurately. The other panels of Fig. 8 show the most likely docking configurations (as estimated by having the lowest software-predicted binding energies as summarized in Table 1 ) of each inhibitor around the molybdopterin catalytic site of XO. These images revealed that two purpurogallins bind more closely to the molybdenum of the XO than do the pyrogallols. Fig. 9 shows the interactions amino acid residues of the XO active site with the bound pyrogallol and purpurogalin molecules; these interactions were deduced by LigPlot+, using a previously reported protocol [31] . Specifically, docked purpurogallin appeared to be stabilized at −11.0 kcal mol
, possibly by two hydrogen bonds with Arg880 (2.79 and 2.93 Å), three hydrogen bonds with Thr1010 (2.70, 2.83, and 3.00 Å), and one hydrogen bond with Val1011 (2.93 Å); docking stabilization may have also been enhanced by hydrophobic interactions with the hydrophobic moieties of Glu802, Leu873, Phe914, Phe1009, Leu1014, Ala1078, Ala1079, Glu1261, and Mte1333 (molybdopterin) (Fig. 9 A) . In contrast, docked pyrogallol speared to have lower stability (predicted binding energy is −7.6 kcal mol ) derived from interactions with polar amino acids through hydrogen bonds [specifically, three with Arg880 (2.99, 2.93, and 3.31 Å) and four with Thr1010 (2.79, 2.93, 2.97, and 3.48 Å)] and with interactions with fewer hydrophilic amino acids (Glu802, Phe914, Phe1009, and Ala1079) (Fig. 9B) . Additional AutoDock simulations provided the next lower binding energies for 1,7-dimetylpurpurogallin in the FAD and molybdopterin regions of XO, which were −9.2 kcal mol −1 and −9.1 kcal -
, respectively (Table 1 ). The XO-inhibitory efficiencies of both purpurogallins (IC 50 =0. ) ( Table 1) . XO contains many hydrophobic amino acid residues, such as phenylalanine and leucine, on the surface of the catalytic site. Methyl substitution enhances the hydrophobicity of the mother compounds; therefore, it can raise their binding affinities for XO by increasing hydrophobic interactions, unless steric hindrance becomes an issue. The relatively higher binding energies of 4-methylpyrogallol and 5-methylpyrogallol compared to that of pyrogallol could be explained by their enhanced hydrophobicity. However, their higher IC 50 values (which translates to have lower inhibitory activity), especially that of 5-methylpyrogallol, could not be explained by binding affinity. We noted that, under alkaline conditions, no substitution of the carbon in the 5-position is necessary to produce the purpurogallin structure; the final step for purpurogallin formation requires deprotonation and subsequent enolisation at the 5-position of pyrogallol [32] . Therefore, 5-methylpyrogallol could not accommodate any corresponding compound bearing purpurogallin structure, and it showed no XO-inhibitory activity as a result.
No study has yet reported on the plasma concentration of purpurogallin after its administration. However, some biological activities of orally administrated purpurogallin have been observed in laboratory animals (Mammalia) [33] [34] [35] . The results of those studies indicate that purpurogallin is absorbed in mammalian bodies through the gastro- intestinal track and then manifest its activities. Recently, the bioavailability of various polyphenols, including those in coffee (ca.150 mg polyphenols in a cup of coffee), was well investigated [36] [37] [38] [39] . The results showed that the maximum concentrations (Cmax) of polyphenols in plasma are not high, but are observed in the range of nmol L
to low-µmol L −1 [40] . An effective plasma concentration of purpurogallin, which can be estimated from its IC 50 value (0.
), is achievable by ingesting purpurogallin-containing foods. Although freshly brewed coffee does not contain purpurogallin, purpurogallin can be formed in the small intestine from pyrogallol present in drinkable coffee, because the small intestine has an alkaline environment. The amount of pyrogallol in roasted coffee was reported to be higher (4-8 µg/g liquid coffee) than that in other liquid beverages such as beer (0.05-0.3 µg/g beer) [41] . Pyrogallol was also observed in mammalian plasma as a catabolite of some polyphenols of black tea or berries [42, 43] . The half-life of pyrogallol in plasma was measured to be within 1 h [44] . This indicates that pyrogallol is found in an unstable form in the plasma (pH 7.4) and is rapidly sulphated [43] or, possibly, converted to purpurogallin, as observed in the present in vitro investigation. The mechanisms of action of not only pyrogallol but also purpurogallin in the living body are still unclear. Further studies are necessary to understand the bioavailability and mechanism of in vivo XO inhibitory activity of both compounds as well as their source, coffee.
In conclusion, the conversion of pyrogallol into purpurogallin in alkaline conditions (including at the physiological model condition of pH 7.4) should be considered an important step in the mechanism of the potent XO-inhibition effects shown by pyrogallol and probably by pyrogallol-contained roasted coffee, -regardless of whether pyrogallol itself is responsible for the XO-inhibitory activity.
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